Global Transplant Serology Diagnostic Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Transplant Serology Diagnostic market size will reach US$ 3955 million by 2031.
Transplant serology diagnostic is a diagnostic approach in the field of transplantation medicine. It mainly involves the detection and analysis of various serological markers in the blood of donors and recipients. These markers include, but are not limited to, human leukocyte antigens (HLA) antibodies, ABO blood - group antigens and antibodies, and other relevant immunoglobulins. By conducting such serological tests, it is possible to assess the immunological compatibility between the donor and the recipient. This information is crucial for determining the suitability of a transplant, predicting the risk of rejection, and guiding the selection of appropriate immunosuppressive therapies. Transplant serology diagnostic plays a fundamental role in ensuring the success of organ or tissue transplantation procedures.
United States market for Transplant Serology Diagnostic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Transplant Serology Diagnostic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Transplant Serology Diagnostic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Transplant Serology Diagnostic players cover Abbott, Bio-Rad Laboratories, QIAGEN N.V., Bruker Corporation, F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Transplant Serology Diagnostic Industry Forecast” looks at past sales and reviews total world Transplant Serology Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Transplant Serology Diagnostic sales for 2025 through 2031. With Transplant Serology Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transplant Serology Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Transplant Serology Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transplant Serology Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transplant Serology Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transplant Serology Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transplant Serology Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Transplant Serology Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Instruments
Kits and Reagents
Software and Services
Segmentation by Application:
Hospitals
Transplant Centers
Research Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Bio-Rad Laboratories
QIAGEN N.V.
Bruker Corporation
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific
Becton, Dickinson and Company
QuidelOrtho Corporation
bioMérieux
Illumina
Siemens Healthineers
Agilent Technologies
Takara Bio Inc.
Hologic
Werfen
DiaSorin
Please note: The report will take approximately 2 business days to prepare and deliver.
Transplant serology diagnostic is a diagnostic approach in the field of transplantation medicine. It mainly involves the detection and analysis of various serological markers in the blood of donors and recipients. These markers include, but are not limited to, human leukocyte antigens (HLA) antibodies, ABO blood - group antigens and antibodies, and other relevant immunoglobulins. By conducting such serological tests, it is possible to assess the immunological compatibility between the donor and the recipient. This information is crucial for determining the suitability of a transplant, predicting the risk of rejection, and guiding the selection of appropriate immunosuppressive therapies. Transplant serology diagnostic plays a fundamental role in ensuring the success of organ or tissue transplantation procedures.
United States market for Transplant Serology Diagnostic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Transplant Serology Diagnostic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Transplant Serology Diagnostic is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Transplant Serology Diagnostic players cover Abbott, Bio-Rad Laboratories, QIAGEN N.V., Bruker Corporation, F. Hoffmann-La Roche Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Transplant Serology Diagnostic Industry Forecast” looks at past sales and reviews total world Transplant Serology Diagnostic sales in 2024, providing a comprehensive analysis by region and market sector of projected Transplant Serology Diagnostic sales for 2025 through 2031. With Transplant Serology Diagnostic sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Transplant Serology Diagnostic industry.
This Insight Report provides a comprehensive analysis of the global Transplant Serology Diagnostic landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Transplant Serology Diagnostic portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Transplant Serology Diagnostic market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Transplant Serology Diagnostic and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Transplant Serology Diagnostic.
This report presents a comprehensive overview, market shares, and growth opportunities of Transplant Serology Diagnostic market by product type, application, key players and key regions and countries.
Segmentation by Type:
Instruments
Kits and Reagents
Software and Services
Segmentation by Application:
Hospitals
Transplant Centers
Research Laboratories
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott
Bio-Rad Laboratories
QIAGEN N.V.
Bruker Corporation
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific
Becton, Dickinson and Company
QuidelOrtho Corporation
bioMérieux
Illumina
Siemens Healthineers
Agilent Technologies
Takara Bio Inc.
Hologic
Werfen
DiaSorin
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
127 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Transplant Serology Diagnostic Market Size by Player
- 4 Transplant Serology Diagnostic by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Transplant Serology Diagnostic Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
